Literature DB >> 25728213

Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance.

Luke W Arbogast1, Robert G Brinson1, John P Marino1.   

Abstract

Monoclonal antibodies (mAbs) represent an important and rapidly growing class of biotherapeutics. Correct folding of a mAb is critical for drug efficacy, while misfolding can impact safety by eliciting unwanted immune or other off-target responses. Robust methods are therefore needed for the precise measurement of mAb structure for drug quality assessment and comparability. To date, the perception in the field has been that NMR could not be applied practically to mAbs due to the size (∼150 kDa) and complexity of these molecules, as well as the insensitivity of the method. The feasibility of applying NMR methods to stable isotope-labeled, protease-cleaved, mAb domains (Fab and Fc) has been demonstrated from both E. coli and Chinese hamster ovaries (CHO) cell expression platforms; however, isotopic labeling is not typically available when analyzing drug products. Here, we address the issue of feasibility of NMR-based mapping of mAb structure by demonstrating for the first time the application of a 2D (13)C NMR methyl fingerprint method for structural mapping of an intact mAb at natural isotopic abundance. Further, we show that 2D (13)C NMR spectra of protease-cleaved Fc and Fab fragments can provide accurate reporters on the domain structures that can be mapped directly to the intact mAb. Through combined use of rapid acquisition and nonuniform sampling techniques, we show that these Fab and Fc fingerprint spectra can be rapidly acquired in as short as approximately 30 min.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728213     DOI: 10.1021/ac504804m

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  40 in total

1.  2D (1)H(N), (15)N Correlated NMR Methods at Natural Abundance for Obtaining Structural Maps and Statistical Comparability of Monoclonal Antibodies.

Authors:  Luke W Arbogast; Robert G Brinson; Trina Formolo; J Todd Hoopes; John P Marino
Journal:  Pharm Res       Date:  2015-10-09       Impact factor: 4.200

2.  Spin Diffusion Editing for Structural Fingerprints of Therapeutic Antibodies.

Authors:  Joshua Franks; John N Glushka; Michael T Jones; David H Live; Qin Zou; James H Prestegard
Journal:  Anal Chem       Date:  2015-12-22       Impact factor: 6.986

3.  Evaluation of Ion Mobility-Mass Spectrometry for Comparative Analysis of Monoclonal Antibodies.

Authors:  Carly N Ferguson; Ashley C Gucinski-Ruth
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-17       Impact factor: 3.109

4.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

5.  Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR.

Authors:  Dinen D Shah; Surinder M Singh; Krishna M G Mallela
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

6.  Multivariate Analysis of Two-Dimensional 1H, 13C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order Structure.

Authors:  Luke W Arbogast; Frank Delaglio; John E Schiel; John P Marino
Journal:  Anal Chem       Date:  2017-10-14       Impact factor: 6.986

7.  1H, 13C, 15N backbone and side chain resonance assignment of the HNH nuclease from Streptococcus pyogenes CRISPR-Cas9.

Authors:  Helen B Belato; Kyle W East; George P Lisi
Journal:  Biomol NMR Assign       Date:  2019-08-03       Impact factor: 0.746

8.  Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.

Authors:  Kang Chen; Junyong Park; Feng Li; Sharadrao M Patil; David A Keire
Journal:  AAPS PharmSciTech       Date:  2017-11-06       Impact factor: 3.246

9.  Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure.

Authors:  Kang Chen; Dianna S Long; Scott C Lute; Michaella J Levy; Kurt A Brorson; David A Keire
Journal:  J Pharm Biomed Anal       Date:  2016-06-07       Impact factor: 3.935

10.  Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab.

Authors:  Giovanna Scapin; Xiaoyu Yang; Winifred W Prosise; Mark McCoy; Paul Reichert; Jennifer M Johnston; Ramesh S Kashi; Corey Strickland
Journal:  Nat Struct Mol Biol       Date:  2015-11-23       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.